Adrenocorticotropic Hormone (ACTH), Plasma, Eight Specimens
Use
The Adrenocorticotropic Hormone (ACTH) Plasma test is used to diagnose or rule out conditions related to abnormal hormone levels, such as Cushing's disease and Addison's disease. The test is generally ordered as part of a series for dynamic endocrine testing, which requires drawing multiple specimens over time to evaluate the patient's response to a stimulus, such as a medication or a physiological challenge. Monitoring ACTH levels can help guide treatment and management of disorders affecting the pituitary gland or adrenal glands.
Special Instructions
This test requires careful coordination and timing as it involves the collection of eight separate plasma specimens at defined intervals, typically in response to an administered medication or treatment (e.g., glucola). Physicians must be consulted before the series is ordered to ensure the necessity of the testing. Additionally, patients should discontinue biotin supplements at least 72 hours prior to specimen collection to avoid assay interference.
Limitations
This test may not be accurate for patients currently taking or recently having taken biotin supplements, as high doses can interfere with the assay results. Proper timing and adherence to specimen collection procedures are crucial for reliable results. The test also requires careful handling and processing of multiple time-point specimens, which may introduce variability if not managed correctly.
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 42598-3
- 42598-3
- 39564-0
- 12458-6
- 12459-4
- 12460-2
- 12461-0
- 12462-8
- 12463-6
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
Not provided
Minimum Volume
Not provided
Container
Special ACTH tube
Collection Instructions
Collect blood in a special ACTH tube. Multiple specimens should be collected at specific time intervals as prescribed. Ensure tubes are labeled in sequence and transport them promptly to the laboratory.
Patient Preparation
Patients should discontinue biotin supplements at least 72 hours prior to specimen collection.
Storage Instructions
Plasma should be separated and frozen if not immediately transported to the lab.
Causes for Rejection
Specimens collected from patients consuming high doses of biotin.
